Published in Psychopharmacology (Berl) on August 16, 2011
Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder. PLoS One (2017) 0.75
Serotonin transporter gene promoter methylation status correlates with in vivo prefrontal 5-HTT availability and reward function in human obesity. Transl Psychiatry (2017) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry (2007) 4.71
Somatoform disorders in general practice: prevalence, functional impairment and comorbidity with anxiety and depressive disorders. Br J Psychiatry (2004) 2.62
Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A (1997) 2.50
Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am J Psychiatry (2006) 2.31
Culture and somatization: clinical, epidemiological, and ethnographic perspectives. Psychosom Med (1998) 2.18
Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet (1999) 2.16
Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Soc Clin Psychol (1977) 1.67
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther (2004) 1.53
No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse (2003) 1.44
The human serotonin transporter gene polymorphism--basic research and clinical implications. J Neural Transm (Vienna) (1997) 1.39
Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry (2002) 1.24
Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. J Neural Transm (Vienna) (2007) 1.19
Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. Neuroimage (2007) 1.17
Central serotonin transporter availability measured with [123I]beta-CIT SPECT in relation to serotonin transporter genotype. Am J Psychiatry (2004) 1.15
Sex differences in diencephalon serotonin transporter availability in major depression. Biol Psychiatry (2005) 1.09
Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry (2003) 1.04
123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. J Nucl Med (2005) 1.02
Variants of the serotonin transporter gene and NEO-PI-R Neuroticism: No association in the BLSA and SardiNIA samples. Am J Med Genet B Neuropsychiatr Genet (2009) 1.01
Psychological vulnerability differences in students--carriers or not of the serotonin transporter promoter allele S: effect of adverse experiences. Synapse (2009) 0.96
Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biol Psychiatry (2004) 0.95
Gender differences in association between serotonin transporter gene polymorphism and personality traits. Psychiatr Genet (2000) 0.95
2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand. Nucl Med Biol (2000) 0.93
Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors. Brain Res (1999) 0.92
Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder? A meta-analysis. Psychosom Med (1998) 0.92
[123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol Psychiatry (2000) 0.91
Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry (1999) 0.90
Psychobiological differences between depression and somatization. J Psychosom Res (2010) 0.90
Measuring psychiatric disorder among Southeast Asian refugees. Psychol Med (1986) 0.88
Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT. J Nucl Med (2001) 0.88
Reduced brain serotonin transporter binding in patients with panic disorder. Psychiatry Res (2004) 0.86
Serotonin transporter binding in Tourette Syndrome. Neurosci Lett (2005) 0.85
Relationship between neuroticism personality trait and serotonin transporter binding. Biol Psychiatry (2007) 0.85
Is there an association between serotonin transporter gene polymorphism and family history of depression? J Affect Disord (2003) 0.84
Stability of neuroticism and alexithymia in somatization. Compr Psychiatry (2003) 0.84
Mechanism of action of antidepressants. Psychopharmacol Bull (2002) 0.84
Somatization and chronic pain. Acta Anaesthesiol Scand (2001) 0.83
2-(2-(dimethylaminomethyl)phenoxy)-5-iodophenylamine: an improved serotonin transporter imaging agent. J Med Chem (2004) 0.80
Pharmacotherapy of somatoform disorders. J Psychosom Res (2004) 0.80
Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study. Psychiatry Res (2010) 0.80
Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry (1990) 0.78
The relationships between daily life events and the availabilities of serotonin transporters and dopamine transporters in healthy volunteers--a dual-isotope SPECT study. Neuroimage (2008) 0.78
The interaction of serotonin depletion with anxiolytics and antidepressants on reticular-elicited hippocampal RSA. Neuropharmacology (1994) 0.77
DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer. J Neurochem (2004) 0.76
Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM. Psychiatry Res (2007) 0.76
[Panic, somatization and exercise]. Rev Med Brux (2006) 0.75
Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.56
The risk factors of Internet addiction--a survey of university freshmen. Psychiatry Res (2009) 1.52
Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol (2008) 1.38
A study on the sleep quality of incoming university students. Psychiatry Res (2012) 1.27
Name change for schizophrenia. Schizophr Bull (2014) 1.08
Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study. Neuroimage (2007) 1.04
A single exposure to iron oxide nanoparticles attenuates antigen-specific antibody production and T-cell reactivity in ovalbumin-sensitized BALB/c mice. Int J Nanomedicine (2011) 0.99
Study on the neuroprotective effect of fluoxetine against MDMA-induced neurotoxicity on the serotonin transporter in rat brain using micro-PET. Neuroimage (2009) 0.96
Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study. Psychiatry Res (2008) 0.95
Decreased dopamine transporter availability in male smokers -- a dual isotope SPECT study. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.95
Anti-NMDA receptor encephalitis with the initial presentation of psychotic mania. J Clin Neurosci (2012) 0.94
Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice. Int Immunopharmacol (2007) 0.93
The amygdala excitatory/inhibitory balance in a valproate-induced rat autism model. PLoS One (2013) 0.93
Psychiatric morbidity and posttraumatic symptoms among earthquake victims in primary care clinics. Gen Hosp Psychiatry (2003) 0.93
Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy. Psychiatry Clin Neurosci (2003) 0.92
High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord (2009) 0.91
The role of valproate in metabolic disturbances in bipolar disorder patients. J Affect Disord (2010) 0.90
A comparative study on cannabidiol-induced apoptosis in murine thymocytes and EL-4 thymoma cells. Int Immunopharmacol (2008) 0.90
Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics (2008) 0.90
MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence. Alcohol Clin Exp Res (2010) 0.89
Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav Immun (2011) 0.88
The functionality and economic costs of outpatients with schizophrenia in Taiwan. Psychiatry Res (2008) 0.88
The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder. Am J Med Genet B Neuropsychiatr Genet (2012) 0.88
Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls. Psychiatry Res (2003) 0.87
Smoking and psychosis in patients with bipolar I disorder. Compr Psychiatry (2002) 0.87
Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol (2012) 0.87
Drynaria fortunei J. Sm. promotes osteoblast maturation by inducing differentiation-related gene expression and protecting against oxidative stress-induced apoptotic insults. J Ethnopharmacol (2010) 0.87
Imaging of regional metabolic activity by (18)F-FDG/PET in rats with transient cerebral ischemia. Appl Radiat Isot (2009) 0.86
Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers--a SPECT study. Neuroimage (2011) 0.86
Challenges in treating patients with major depressive disorder: the impact of biological and social factors. CNS Drugs (2013) 0.85
Targeting to overexpressed glucose-regulated protein 78 in gastric cancer discovered by 2D DIGE improves the diagnostic and therapeutic efficacy of micelles-mediated system. Proteomics (2012) 0.85
Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia. Psychiatry Res (2004) 0.85
The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder. J Affect Disord (2012) 0.85
Long-acting injectable antipsychotics for first-episode schizophrenia: the pros and cons. Schizophr Res Treatment (2012) 0.85
Associated alterations of striatal dopamine D2/D3 receptor and transporter binding in drug-naive patients with schizophrenia: a dual-isotope SPECT study. Am J Psychiatry (2004) 0.85
Correlation between different memory systems and striatal dopamine D2/D3 receptor density: a single photon emission computed tomography study. Psychol Med (2005) 0.84
Correlation between striatal dopamine D2 receptor density and neuroticism in community volunteers. Psychiatry Res (2005) 0.83
Availability of dopamine and serotonin transporters in opioid-dependent users--a two-isotope SPECT study. Psychopharmacology (Berl) (2011) 0.83
Norms of performance of sustained attention among a community sample: Continuous Performance Test study. Psychiatry Clin Neurosci (2005) 0.83
The ALDH2 and 5-HT2A genes interacted in bipolar-I but not bipolar-II disorder. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.83
Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disord (2010) 0.83
Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder. J Psychiatr Res (2013) 0.83
Association of novelty seeking scores and striatal dopamine D₂/D₃ receptor availability of healthy volunteers: single photon emission computed tomography with ¹²³i-iodobenzamide. J Formos Med Assoc (2010) 0.83
Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers. J Psychiatry Neurosci (2010) 0.82